RAPHRAPHAEL PHARMACEUTICAL INC.

About RAPHAEL PHARMACEUTICAL INC. (RAPH)

RAPHAEL PHARMACEUTICAL INC. (RAPH) is a Drug Manufacturers - Specialty & Generic company headquartered in Tel Aviv Jaffa, Israel whose shares trade over-the-counter on the OTCQB tier.

Discovery and Clinical development of life -improving drug therapies based on Cannabinoids , including cannabidiol oil.

Products and services

Discovery and Clinical development of life -improving drug therapies based on Cannabinoids , including cannabidiol oil.

RAPH key facts

Ticker symbol

RAPH

Market tier

OTCQB

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Tel Aviv Jaffa, Israel

Country of incorporation

US

Year of incorporation

2007

Estimated market cap

$4.35M (as of May 8, 2025)

Shares outstanding

19,626,418

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

RAPHAEL PHARMACEUTICAL INC. leadership

• Shlomo Pilo — CEO, Executive Director
• Guy Ofir — CFO, Executive Director
• Igal Louria Hayon — CTO, Executive Director

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · OTCQB stocks · OTC stocks starting with R